Genocea Biosciences, Inc.
GNCA
GNCA was delisted on the 2nd of June, 2022.
59 hedge funds and large institutions have $136M invested in Genocea Biosciences, Inc. in 2016 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 16 increasing their positions, 16 reducing their positions, and 10 closing their positions.
54% more capital invested
Capital invested by funds: $87.8M → $136M (+$47.8M)
20% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 10
4% more funds holding
Funds holding: 57 → 59 (+2)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 16
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
+$3.09M |
| 2 |
NC
Northpointe Capital
Bloomfield Hills,
Michigan
|
+$2.21M |
| 3 |
PA
Perceptive Advisors
New York
|
+$2.05M |
| 4 |
AA
AlphaMark Advisors
Ft. Wright,
Kentucky
|
+$900K |
| 5 |
AIC
AWM Investment Company
New York
|
+$596K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
Broadfin Capital
New York
|
-$4.46M |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
-$823K |
| 3 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$709K |
| 4 |
Millennium Management
New York
|
-$565K |
| 5 |
TI
Trexquant Investment
Stamford,
Connecticut
|
-$368K |
GNCA Hedge Fund Activity: Q1 2016 in Review
59 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Genocea Biosciences, Inc. (GNCA) for Q1 2016, worth a combined $136M — up 54% from $87.8M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new GNCA positions and 10 closed out — a net gain of 2 holders — while 16 added to existing stakes and 16 trimmed.
The largest buyer was Franklin Resources, adding an estimated $3.09M. The largest seller was Broadfin Capital, exiting entirely with an estimated $4.46M sold.
- 59 institutional investors held Genocea Biosciences, Inc. (GNCA) as of Q1 2016, up from 57 in Q4 2015.
- Funds reported $136M of Genocea Biosciences, Inc. stock for Q1 2016, up 54% quarter-over-quarter.
- 12 funds opened new Genocea Biosciences, Inc. positions in Q1 2016 and 10 closed out, a net change of +2 holders.
- The largest Genocea Biosciences, Inc. buyer in Q1 2016 was Franklin Resources, an estimated $3.09M added.
- The largest Genocea Biosciences, Inc. seller in Q1 2016 was Broadfin Capital, an estimated $4.46M sold.
Based on aggregated 13F filings for Q1 2016.